Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.59 USD | -4.29% | -5.33% | +56.70% |
May. 14 | Stephens Starts Inovio Pharmaceuticals With Overweight Rating, $20 Price Target | MT |
May. 13 | Transcript : Inovio Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 13, 2024 |
Financials (USD)
Sales 2024 * | 348K | Sales 2025 * | 19.8M | Capitalization | 260M |
---|---|---|---|---|---|
Net income 2024 * | -121M | Net income 2025 * | -108M | EV / Sales 2024 * | 746 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 13.1 x |
P/E ratio 2024 * |
-2.17
x | P/E ratio 2025 * |
-3.01
x | Employees | 122 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.4% |
Latest transcript on Inovio Pharmaceuticals, Inc.
1 day | -4.29% | ||
1 week | -5.33% | ||
Current month | -5.33% | ||
1 month | -13.99% | ||
3 months | +6.20% | ||
6 months | +111.42% | ||
Current year | +56.70% |
Managers | Title | Age | Since |
---|---|---|---|
Jacqueline Shea
CEO | Chief Executive Officer | 58 | 19-03-24 |
Peter Kies
DFI | Director of Finance/CFO | 60 | 02-05-31 |
Chief Tech/Sci/R&D Officer | - | 07-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Benito
CHM | Chairman | 79 | 03-11-30 |
Lota Zoth
BRD | Director/Board Member | 64 | 17-12-31 |
Jay Shepard
BRD | Director/Board Member | 66 | 20-01-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 9.59 | -4.29% | 234,516 |
24-06-06 | 10.02 | -1.09% | 185,988 |
24-06-05 | 10.13 | +0.40% | 226,367 |
24-06-04 | 10.09 | -0.69% | 190,115 |
24-06-03 | 10.16 | +0.30% | 224,421 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.70% | 248M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- INO Stock